Baxter International (BAX) Cash from Discontinued Operations (2014 - 2025)
Baxter International (BAX) reported Cash from Discontinued Operations of 12000000.0 for Q4 2025, down 126.67% year-over-year from 45000000.0 in Q4 2024, and up 87.23% quarter-over-quarter from 94000000.0 in Q1 2025.
Baxter International (BAX) Cash from Discontinued Operations (2014 - 2025) Analysis & Trends
Baxter International (BAX) has 11 years of Cash from Discontinued Operations data on file, last reported at 12000000.0 in Q4 2025.
- Cash from Discontinued Operations for Q4 2025 came in at 12000000.0, down 126.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 12000000.0 (down 220.0% YoY), and the FY2025 annual result was 106000000.0, down 153.0% from the prior year.
- Cash from Discontinued Operations improved to 12000000.0 in Q4 2025 per BAX's latest filing, from 94000000.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 505000000.0 in Q4 2022 and troughed at 94000000.0 in Q1 2025.
- A 5-year average of 106076923.08 and a median of 65000000.0 in 2022 frame the typical range for Cash from Discontinued Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Discontinued Operations jumped 860.0% in 2024, then slumped 197.92% in 2025.
- A 5-year view of Cash from Discontinued Operations shows it stood at 196000000.0 in 2021, then jumped by 157.65% to 505000000.0 in 2022, then tumbled by 77.03% to 116000000.0 in 2023, then tumbled by 61.21% to 45000000.0 in 2024, then plunged by 126.67% to 12000000.0 in 2025.
- Business Quant data shows BAX's Cash from Discontinued Operations at 12000000.0 in Q4 2025, 94000000.0 in Q1 2025, and 45000000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.00 Mn |
| Dec 31, 2025 | -12.00 Mn |
| Mar 31, 2025 | -94.00 Mn |
| Mar 31, 2025 | -94.00 Mn |
| Dec 31, 2024 | 45.00 Mn |
| Dec 31, 2024 | 45.00 Mn |
| Sep 30, 2024 | -93.00 Mn |
| Sep 30, 2024 | -93.00 Mn |
| Jun 30, 2024 | 152.00 Mn |
| Jun 30, 2024 | 152.00 Mn |
| Mar 31, 2024 | 96.00 Mn |
| Mar 31, 2024 | 96.00 Mn |
| Dec 31, 2023 | 116.00 Mn |
| Dec 31, 2023 | 116.00 Mn |
| Sep 30, 2023 | 353.00 Mn |
| Sep 30, 2023 | 353.00 Mn |
| Jun 30, 2023 | 40.00 Mn |
| Jun 30, 2023 | 40.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Mar 31, 2023 | 10.00 Mn |